Search for Clinical Trials
S2303 PARAMMUNE: Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-…
Introduction: Comorbidities pose significant challenges to the delivery of quality cancer treatment. Medically underserved patients have the highest…
Introduction: Surgery is a cornerstone of treatment for gastrointestinal (GI) cancers, but it is associated with high risk of rehospitalization and…
